Study of IBI318 in Participants With Advanced Malignancies

NCT03875157 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

103

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Malignancy

Interventions

BIOLOGICAL: IBI318
BIOLOGICAL: IBI318
BIOLOGICAL: IBI318
BIOLOGICAL: IBI318
BIOLOGICAL: IBI318
BIOLOGICAL: IBI318
BIOLOGICAL: IBI318
BIOLOGICAL: IBI318
BIOLOGICAL: IBI318
BIOLOGICAL: IBI318
BIOLOGICAL: IBI318

Sponsor

Innovent Biologics (Suzhou) Co. Ltd.